Key Deal Facts
Backed by Sand Hill Angels (SweetGarden, Ro, Masterclass, Parsley Health and many other major exits)
Incubated by Johnson & Johnson JLABS, accelerated by Stanford’s StartX
Multiple exits & two IPOs achieved by team of experts from Medtronic, Boston Scientific, Stanford
39 devices implanted in 2024 at world-renowned medical centers
60,000+ hours of cardiac data powering AI insights
$110B implantable medical device market
Forecasting $40M+ in revenue within 5 years
Limited players, Premium Pricing. High value to patients and physicians with simplicity and accuracy
Management Team / Advisory Board Bios
VC-Backed
Raised $250K or more from a venture firm, Jaeson Bang Founder & CEO Cardiology & medtech startup trailblazer. 20+ years of experience in clinical, business and tech operations at Silicon Valley startups and Medtronic and Abiomed. $13M raised from angel investors. Northwestern University, Kellogg School of Management MBA., Anatoly Yakovlev, PhDData ScientistBiomedical engineer & AI maestro. Neuro-modulations and machine learning expert. Leading AI innovations at Oracle (NYSE: ORCL). Stanford University PhD., Adam GullicksonVP of OperationsMedtech leader & regulation guru. R&D, manufacturing, quality, and regulatory expert with 21 years experience. Specializes in navigating regulatory pathways to lead teams to market. University of Minnesota, Biomedical Engineering., Steve ZielinksiVP of Systems Engineering and SoftwareMedical device R&D veteran. 20+ years of experience. Expert in systems development and AI applications. Led the development of Coloplast's first active implantable neuromodulation device. University of Minnesota BEE, University of St. Thomas MSDD., Dimitrios Georgakopoulos, PhDScience AdvisorHeart health expert & seasoned medtech scientist. 25+ years of expertise in heart failure and cardiac hemodynamics. Former Chief Science Officer at Sunshine Heart Inc. (NASDAQ: SSH). Johns Hopkins University PhD., Dr. Dan Burkhoff, MD PhDMedical AdvisorWorld-renowned cardiologist & scientist. Leader in heart failure and medtech startups with multiple exits. Former VP at Heartware ($1.2B acquisition by Medtronic). Columbia University MD PhD., Dr. Kevin Heist, MD PhDMedical AdvisorLeading cardiologist & electrophysiology, currently Associate Professor at Harvard Medical School Special focus on treating cardiac arrhythmias at Mass General Hospital in Boston. Stanford University MD PhD., Dr. Toshi Okabe, MDMedical AdvisorElectrophysiology cardiologist & arrhythmia specialist. Expertise in cardiac arrhythmia management and performing cardiac ablations. Practicing cardiologist at Ohio State University. University of Tokyo MD.